Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Invested Capital (2022 - 2025)

Prokidney (PROK) has disclosed Invested Capital for 4 consecutive years, with -$1.0 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 1.63% to -$1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 billion through Dec 2025, down 1.63% year-over-year, with the annual reading at -$1.0 billion for FY2025, 1.63% down from the prior year.
  • Invested Capital for Q4 2025 was -$1.0 billion at Prokidney, roughly flat from -$1.0 billion in the prior quarter.
  • The five-year high for Invested Capital was $20.2 million in Q1 2022, with the low at -$1.6 billion in Q1 2023.
  • Average Invested Capital over 4 years is -$959.3 million, with a median of -$1.0 billion recorded in 2025.
  • The sharpest move saw Invested Capital plummeted 20080.61% in 2023, then skyrocketed 31.56% in 2024.
  • Over 4 years, Invested Capital stood at -$1.1 billion in 2022, then dropped by 0.62% to -$1.1 billion in 2023, then increased by 9.83% to -$995.0 million in 2024, then fell by 1.63% to -$1.0 billion in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$1.0 billion, -$1.0 billion, and -$1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.